Dear Sir, Please find the attached Outcome of the BM held on 14-10-2025 at 5.30 pm. Kindly acknowledge the same
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories Ltd is seeking shareholder approval via postal ballot to sell its pharmaceutical formulations factory at Sinnar, Nashik and its registered office premises at Bhandup West, Mumbai. The factory, in operation since 1995-1998, needs major upgrades to meet revised WHO Schedule M norms, which the company finds too expensive — it plans to either build a new plant in Gujarat or buy a ready-made compliant facility instead. The 25-year-old office building also lacks basic facilities and cannot be redeveloped due to a nearby electric tower. Both assets will be sold on a slump sale basis at not less than Rs. 3 Crores each (combined minimum Rs. 6 Crores). E-voting runs from October 15, 2025 to November 14, 2025, with a cut-off date of October 7, 2025.
This is a significant asset sale for shareholders — the company is disposing of both its manufacturing base and registered office, meaning core operations are being wound down or relocated. If approved, Rs. 6 Crores+ will come into the company for redeployment, but investors should watch for clarity on the new factory plan and any potential business disruption during the transition.